PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-1153

  1. 3,019 Posts.
    lightbulb Created with Sketch. 1846
    100% agreed, he could and should have been more professionally presented. Thankfully the results are so good and that’s really all anyone including large Pharma will be interested in.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.